For someone weighing 200 pounds, thats 30-44 pounds of sustained weight loss
Full medical history, current medications, and prior weight-loss attempts Contraindications, including thyroid and pancreatic history Prior experience with GLP-1 medications, if any Realistic goals, timeline, and appropriate starting dose Whether in-clinic dosing or an eventual take-home protocol fits your schedule Whether a different medical weight-loss approach may be a better fit for you Answer four short questions and well point you to the right next step
It's important to note that FDA-approved semaglutide products (Ozempic and Wegovy) in the US are available as prefilled pens, not vials
Zhong J, Chen H, Liu Q, Zhou S, Liu Z, Xiao Y
However, this approach has also impacted Type 2 diabetes patients access to GLP-1s by requiring some patients to try other diabetes treatments (e.g., blood sugar regulators such as sodium-glucose cotransporter-2 inhibitor Brenzavvy and dipeptidyl peptidase-4 inhibitor Onglyza) before GLP-1 approval